Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis

J Henssler, Y Schmidt, U Schmidt, G Schwarzer… - The Lancet …, 2024 - thelancet.com
Background Antidepressant discontinuation symptoms are becoming an increasingly
important part of clinical practice, but the incidence of antidepressant discontinuation …

[HTML][HTML] Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

APM Lullau, EMW Haga, EH Ronold… - Frontiers in …, 2023 - frontiersin.org
Concurrent with recent insights into the neuroprogressive nature of depression, ketamine
shows promise in interfering with several neuroprogressive factors, and has been suggested …

The serotonin hypothesis of depression: both long discarded and still supported?

J Moncrieff, RE Cooper, T Stockmann… - Molecular …, 2023 - nature.com
We thank the authors of all the letters for their interest in our paper [1]. The reason our paper
is important is that the pharmaceutical industry, along with many doctors and academics …

The potential of scopolamine as an antidepressant in major depressive disorder: a systematic review of randomized controlled trials

P Moćko, K Śladowska, P Kawalec, Y Babii, A Pilc - Biomedicines, 2023 - mdpi.com
Major depressive disorder is one of the most severe mental disorders. It strongly impairs
daily functioning, and, in extreme cases, it can lead to suicide. Although different treatment …

[HTML][HTML] The need for antidepressant withdrawal support services: recommendations from 708 patients

J Read, S Lewis, M Horowitz, J Moncrieff - Psychiatry Research, 2023 - Elsevier
Approximately half of the tens of millions of people currently taking antidepressants will
experience withdrawal symptoms when they try to reduce or come off them. Nearly half of …

RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 …

KA Wallis, M Donald, M Horowitz, J Moncrieff, RS Ware… - Trials, 2023 - Springer
Background Many people experience withdrawal symptoms when they attempt to stop
antidepressants. Withdrawal symptoms are readily misconstrued for relapse or ongoing …

Acceptability and optimisation of resources to support antidepressant cessation: a qualitative think-aloud study with patients in Australian primary care

S McDonald, K Wallis, M Horowitz, E Mann, V Le… - British Journal of …, 2024 - bjgp.org
Background Stopping long-term (> 12 months) antidepressant use can be difficult due to
unpleasant withdrawal symptoms. Many people do not recognise withdrawal symptoms or …

Addiction and physical dependence are not the same thing

MA Horowitz, D Taylor - The Lancet Psychiatry, 2023 - thelancet.com
The term dependence has come to be used interchangeably with addiction in common
language. 1 This conflation originates from the use of the word dependence to describe …

The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study

R Mahmood, V Wallace, N Wiles, D Kessler… - Health …, 2024 - Wiley Online Library
Background Our knowledge of the broader impacts of antidepressant withdrawal, beyond
physical side effects, is limited. Further research is needed to investigate the lived …

Interventions to help patients withdraw from depression drugs: A systematic review

PC Gøtzsche, M Demasi - … Journal of Risk & Safety in …, 2023 - content.iospress.com
BACKGROUND: Depression drugs can be difficult to come off due to withdrawal symptoms.
Gradual tapering with tapering support is needed to help patients withdraw safely …